The Dalkon shield. the intrauterine device used today
Skjeldestad, F.E.
Tidsskrift for den Norske Laegeforening Tidsskrift for Praktisk Medicin Ny Raekke 108(12): 960-961
1988
ISSN/ISBN: 0029-2001 PMID: 3381212 Document Number: 322122
Document emailed within 1 workday
Related Documents
Esposito, J.M.; Zarou, D.M.; Zarou, G.S. 1973: A Dalkon Shield imbedded in a myoma: case report of an unusual displacement of an intrauterine contraceptive device American Journal of Obstetrics and Gynecology 117(4): 578-581Mumford, S.D.; Kessel, E. 1992: Was the Dalkon Shield a safe and effective intrauterine device? the conflict between case-control and clinical trial study findings Fertility and Sterility 57(6): 1151-1176
Badis, C.M.; Hayen, M.; el-H Nadia; Dalila, R.; Lamia, S.; Ezzeddine, S.; Hela, C.; Rim, B.A. 2000: The Dalkon Shield, a forgotten device, responsible for actinomycosis La Tunisie Medicale 78(2): 139-142
Chadwick, J.M. 1975: The Dalkon Shield contraceptive device in general practice Medical Journal of Australia 2(14): 565-566
Ostergard, D.R.; Gunning, J.E. 1976: Intrauterine contraception with the copper T-200 and the Dalkon shield in nulligravid women Journal of Reproductive Medicine 17(3): 172-174
Rioux, J.E.; Cloutier, D.; Dupont, P.; Lamonde, D. 1986: Long-term study of the safety of the Dalkon Shield and Gyne-T 200 intrauterine devices Cmaj: Canadian Medical Association Journal 134(7): 747-751
Earl, T.J. 1971: The shield intrauterine device American Family Physician 4(3): 93
Edelman, D.A.; Berger, G.S.; Keith, L. 1984: Pelvic inflammatory disease and the Dalkon Shield Obstetrics and Gynecology 64(2): 297-300
Thomas, W.O. 1977: The Dalkon Shield, the TCu 200, and the TCu 380A in private practice Transactions of the Pacific Coast Obstetrical and Gynecological Society 44: 78-85
Tuxen, J. 1975: A case of perforation of the uterus with the Dalkon Shield Ugeskrift for Laeger 137(39): 2278-2280
Wang, A.C. 1974: The experience with Dalkon shield in UCLA family planning clinic Nihon Funin Gakkai Zasshi 19: 248-253
Munteanu, O.; Cirstoiu, M.; Antoniac, I.; Cirstoiu, C. 2016: Comparison of Pain Level During and After Intrauterine Device Insertion: Levonorgestrel-Releasing Intrauterine System Versus the Copper T Intrauterine Device Environmental Engineering and Management Journal 15(5): 965-972
Andolsek, L.; Teeter, R.A.; Kozuh Novak, M.; Wheeler, R.; Fortney, J.A.; Rosenberg, M.J. 1986: Time to conception after intrauterine device removal importance of duration of use intrauterine device type pelvic inflammatory disease and age International Journal of Gynecology and Obstetrics 24(3): 217-224
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Brunie, A.él.; Stankevitz, K.; Nwala, A.A.; Nqumayo, M.; Chen, M.; Danna, K.; Afolabi, K.; Rademacher, K.H. 2021: Expanding long-acting contraceptive options: a prospective cohort study of the hormonal intrauterine device, copper intrauterine device, and implants in Nigeria and Zambia LANCET. Global Health 9(10): E1431-E1441
Ozgu-Erdinc, A.S.; Tasdemir, U.G.; Uygur, D.; Aktulay, A.; Tasdemir, N.; Gulerman, H.C. 2014: Outcome of intrauterine pregnancies with intrauterine device in place and effects of device location on prognosis Contraception 89(5): 426-430
Blumenthal, P.D.; Goldthwaite, L.M. 2015: Intrauterine Device Insertion During Cesarean Delivery: the Rising Tide of the Postdelivery Intrauterine Device Obstetrics and Gynecology 126(1): 1-2
Roy, S.; Azen, C. 1994: A reanalysis of the Cu-7 intrauterine contraceptive device clinical trial and the incidence of pelvic inflammatory disease: A paradigm for assessing intrauterine contraceptive device safety American Journal of Obstetrics and Gynecology 170(6): 1606
Wang, K.; Cheng, Y.; Yang, H.; Tang, Y.H.; Jiang, J.; Ji, F.; Li, L.B.; Wu, S.C. 2016: Effectiveness research of medicated γ intrauterine device and medicated genefix intrauterine device inserted immediately after abortion Zhonghua Fu Chan Ke Za Zhi 51(3): 198-203